Posts Tagged “Pharmaceutical”
ShowHide 3rd Party PapersAmerican Enterprise Institute: Overspending on Multi-Source Drugs in Medicaid
Express Scripts: 2009 Drug Trend Report – Solving America’s $162 Billion in Pharmacy-Related Waste
ShowHide Commentary
2010 Potpourri XLIII
by Kevin Roche on Saturday, December 11, 2010
The snow is raging here in Minneapolis, but nothing stops the delivery of our Potpourri, which includes discussion of paybacks on EHRs, the fate of dialysis patients, use of telecommunciations to aid drug adherence, cost savings from select pharmacy networks and hospital readmissions.
Tags: Chronic Disease, HIT, Hospital, Medicare, Pharmaceutical, Telemedicine
Shifts in Drug Marketing Spending
by Kevin Roche on Tuesday, January 26, 2010
Pharmaceutical manufacturers have spent massive amounts of money on sending sales reps to visit individual physicians and on direct-to-consumer advertising, to the point that this spending is often larger than research and development costs. This spending may be shifting in some companies to more internet-based marketing.
Tags: Drugs, Pharmaceutical
GAO Looks at Brand-Name Drug Pricing
by Kevin Roche on Wednesday, January 13, 2010
A GAO report examines the “extraordinary” price increases of brand-name drugs. Some of these increases are very, very large, but many are made by repackagers, not the original manufacturer. Many of the drugs were relatively low-priced to start and there were some understandable reasons for the increases.
Tags: Pharmaceutical
CBO Looks at Pharmaceutical R & D
by Kevin Roche on Tuesday, November 24, 2009
The CBO released a brief report looking at the potential impact of various changes in federal policies on research and development spending for drugs. Current and future policies are not likely to encourage more R & D.
Tags: Drugs, Government, Pharmaceutical
Walgreen’s Quarterly Results
by Kevin Roche on Monday, October 12, 2009
Walgreen’s has reported fiscal fourth quarter results, showing continued prescription growth and highlighting its broader wellness and health management efforts.
Tags: Drugs, Pharmaceutical
Ensuring Drug Safety
by Kevin Roche on Thursday, October 8, 2009
Having taken heat on drug safety, the FDA has issued a new draft guidance on risk mitigation efforts by drug companies.
Tags: Drugs, Government, Pharmaceutical, Regulation
More Personalized Medicine
by Kevin Roche on Tuesday, September 29, 2009
In another personalized medicine development, researchers at UCLA have identified a way to improve depression treatment.
Tags: Drugs, Medical Care, Personalized Medicine, Pharmaceutical
How Comparative Effectiveness Research Can Increase Costs
by Kevin Roche on Monday, September 28, 2009
A recent drug trial illustrates how comparative effectiveness research may actually facilitate more health care spending.
Tags: Comparative Effectiveness, Drugs, Medical Care, Pharmaceutical
Personalized Medicine and Anti-platelet Therapy
by Kevin Roche on Friday, August 28, 2009
Pharmacogenomics is at the forefront of personalized medicine development. Recent research indicates promise in anti-platelet therapy guidance.
Tags: Drugs, Genomics, Medical Care, Personalized Medicine, Pharmaceutical
NEHI Study Estimates Cost of Medication Non-Compliance
by Kevin Roche on Wednesday, August 19, 2009
A recent report from NEHI states that medication therapy non-compliance leads to $290 billion in avoidable medical costs every year.
Tags: Care Management, Drugs, Health Care Costs, Pharmaceutical
Understanding the Pharmaceutical Distribution and Payment System
by Kevin Roche on Monday, August 17, 2009
The physical distribution and payment flows for pharmaceuticals in the United States are very complex. A new report helps explain those processes.
Tags: Drugs, Pharmaceutical
Getting Physicians to Participate in Research
by Kevin Roche on Monday, August 17, 2009
An article examines barriers to physician participation in medical research.
Tags: Medical Care, Medical Research, Pharmaceutical, Physicians, Providers
PBM Quarterly Reports
by Kevin Roche on Friday, August 7, 2009
The three largest PBMs have issued their second quarter results. All appear to be performing well.
Tags: Drugs, Pharmaceutical
Drug Manufacturers Up to Old Tricks
by Kevin Roche on Tuesday, July 21, 2009
Between lobbying and price increases, drug manufacturers are doing a good job of protecting their economic interests.
Tags: Drugs, Health Care Reform, Pharmaceutical
Worksite Health and Medication Adherence
by Kevin Roche on Friday, July 10, 2009
A study indicates that patients who receive medical care and prescriptions at the worksite tend to be more compliant with their drug regimens.
Tags: Pharmaceutical, Workplace, Worksite Health
Don’t Blame Drugs For Cost Issues
by Kevin Roche on Friday, July 10, 2009
The limiting of growth in drug spending is a health care success story.
Tags: Drugs, Health Care Costs, Pharmaceutical
Study Looks At Part D Impact on Drug and Medical Spending
by Kevin Roche on Tuesday, June 30, 2009
A study reported in the current issue of NEJM indicates that enrollment in Part D significantly increased drug spending for those persons who previously had no or a low level of drug coverage, but also led to a lower level of medical spending.
Tags: Health Care Costs, Health Insurance, Medicare, Pharmaceutical
ShowHide Headlines
Prescription drug coverage for millions of federal employees and their dependents are at high costs